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Oral diseases continue to be a major public health
problem worldwide, and comments such as ‘You
cannot have good general health without good
oral health’ and ‘The mouth is part of the body’,
while all cliche´s, are gaining an increasing
momentum with the realisation that oral and
systemic health are connected. Several epidemio-
logical studies have indeed linked poor oral
health with cardiovascular diseases, poor glycae-
mic control in diabetics, and low-birth-weight
preterm babies, together with a number of other
diseases, including rheumatoid arthritis and oste-
oporosis. Oral disease is also recognised as a
signiﬁcant problem in medically or immunolog-
ically compromised patients suffering from a
range of chronic conditions.
This publication, based on a symposium held
during the recent 25th ECCMID in Munich,
includes a series of papers which address specif-
ically these issues; the possible mechanisms by
which oral infection and inﬂammation can con-
tribute to cardiovascular disease are covered, as
are the oral conditions associated with medically
compromised patients. The role of antimicrobial
agents such as chlorhexidine and triclosan in the
prevention and control of oral disease, especially
periodontal disease, is also presented. A large
number of clinical studies have established the
clinical efﬁcacy of these agents in the control of
gingivitis and dental plaque and, more recently,
chronic periodontitis in susceptible individuals.
The importance of the role of infection and
inﬂammation in the initiation and progression of
atherosclerosis is now widely accepted. Chronic
inﬂammatory periodontal diseases are found
worldwide and are among the most prevalent
chronic infections in humans. There have now
been over 50 studies investigating the relationship
between periodontal disease and cardiovascular
disease, with the majority showing a signiﬁcant,
albeit modest, association even after adjusting for
confounders. However, any such relationship
must be biologically feasible and the paper by
Seymour et al. (this publication) reviews possible
pathogenic mechanisms, with particular attention
being paid to the role of molecular mimicry
between the bacterial heat-shock protein GroEL
and the human heat-shock protein 60 (hHSP60).
The importance of oral health in patients with
chronic conditions is further taken up by Miglio-
rati and Madrid (this publication), who show, in a
series of elegant case studies, that oral diseases in
medically compromised patients carry a signiﬁ-
cant morbidity and that care of the mouth should
be an integral part of overall medical care. They
note that improvements in longevity have re-
sulted in populations with special needs, such as
the immunosuppressed, the residents of long-
term-care facilities, and those with chronic con-
ditions such as cancer and HIV ⁄AIDS. Migliorati
and Madrid make a strong case that optimal care
for these populations should involve collaborative
efforts between medical and dental professionals
and that this should constitute a central theme for
the training of future healthcare professionals
worldwide.
Good oral hygiene is essential for good oral
health, and in this context the routine control of
dental plaque is fundamental. Yet, the wide-
spread prevalence of oral diseases indicates the
inability of most people to achieve a level of
plaque control consistent with oral health.
Approaches aimed at improving oral hygiene
have included the addition of antibacterial agents
to oral care products. While chlorhexidine is
the reference standard, it does have signiﬁcant
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side-effects that limit its use in the long-term.
Triclosan is an antibacterial agent with a broad
spectrum of activity against oral microorganisms.
It represents a commonly used ingredient in oral
hygiene formulations and has a long history of
safe use in consumer products without signiﬁcant
side-effects.
The consequences of long-term use of any
antimicrobial agent are of concern and the ther-
apeutic advantages have to be weighed against
the possibility of reduced susceptibility and the
emergence of resistant strains. To date, there is no
evidence that the use of triclosan formulations for
oral hygiene selects for triclosan-resistant strains.
This, together with the mechanisms of action of
triclosan, is discussed in detail by Gilbert et al.
(this publication). These authors point out that the
theoretical risks associated with triclosan use in
oral hygiene products are not supported by ﬁeld
or clinical studies (up to 5 years in duration), or
by laboratory studies using bacterial microcosms.
Indeed, Davies (this publication) reviews the now
large number of longitudinal studies of 3–5 years’
duration that show the efﬁcacy of triclosan prod-
ucts in controlling gingivitis and plaque and in
slowing the progression of periodontitis in adults
and adolescents with pre-existing disease. Impor-
tantly, these long-term studies also showed that
continued use over long periods had no detri-
mental effects on either the supragingival or
subgingival microbiota. It is clear, therefore, that
the therapeutic beneﬁts following routine use of
triclosan in oral care products signiﬁcantly out-
weigh the theoretical risks. It is interesting to note
that the major therapeutic beneﬁt, in terms of
chronic periodontitis, is seen in susceptible
patients or those with pre-existing disease. It is
clear that medically and immunologically com-
promised patients represent a population suscep-
tible to such a degree that it would be reasonable
to expect that triclosan-containing oral care prod-
ucts would be of value in the control of oral
infection in these patients.
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